Vertex Pharmaceuticals Incorporated (VRTX)

Vertex Pharmaceuticals Market Cap

Vertex Pharmaceuticals has a market cap or net worth of $101.34 billion as of September 8, 2025. Its market cap has decreased by -19.44% in one year.

• Market Cap: 101.34B
• Enterprise Value: 90.39B
• 1-Year Change: -19.44%
• Ranking: #142
• Category: Large-Cap
• Stock Price: $395.25

Market Cap Chart

Since December 1, 1998, Vertex Pharmaceuticals's market cap has increased from $611.50M to $101.34B, an increase of 16,472.10%. That is a compound annual growth rate of 21.02%.

Market Cap History

Date	Market Cap	% Change
Sep 5, 2025	101.56B	-2.07%
Dec 31, 2024	103.71B	-1.09%
Dec 29, 2023	104.85B	41.44%
Dec 30, 2022	74.13B	32.76%
Dec 31, 2021	55.83B	-9.15%
Dec 31, 2020	61.46B	9.15%
Dec 31, 2019	56.30B	32.95%
Dec 31, 2018	42.35B	11.74%
Dec 29, 2017	37.90B	107.41%
Dec 30, 2016	18.27B	-40.90%
Dec 31, 2015	30.92B	8.21%
Dec 31, 2014	28.57B	64.52%
Dec 31, 2013	17.37B	91.17%
Dec 31, 2012	9.09B	31.16%
Dec 30, 2011	6.93B	-2.69%
Dec 31, 2010	7.12B	-8.32%
Dec 31, 2009	7.76B	69.85%
Dec 31, 2008	4.57B	48.74%
Dec 31, 2007	3.07B	-34.61%
Dec 29, 2006	4.70B	71.34%
Dec 30, 2005	2.74B	223.10%
Dec 31, 2004	848.90M	5.56%
Dec 31, 2003	804.20M	-33.56%
Dec 31, 2002	1.21B	-34.33%
Dec 31, 2001	1.84B	-56.32%

View and export this data all the way back to 1998. Sign Up Today.

Related Stocks

Company	Market Cap
Eli Lilly and Company	652.84B
Johnson & Johnson	429.72B
AbbVie	375.50B
UnitedHealth Group	285.64B
AstraZeneca	253.68B
Novartis AG	252.55B
Novo Nordisk	244.67B
Abbott Laboratories	231.38B